Haemonetics Corporation (HAE)

Haemonetics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Net Income	103.91	97.31	167.68	117.56	115.4	43.38
Depreciation & Amortization	103.48	105.62	108.89	88.62	84.81	86.55
Other Amortization	6.1	6.1	6.7	8.6	8.5	11.8
Loss (Gain) From Sale of Assets	-0.71	-0.71	-15.7	-1.01	-0.94	-9.6
Asset Writedown & Restructuring Costs	77.96	86.55	2.39	10.42	0.61	10.75
Stock-Based Compensation	36.47	33.83	29.64	28.33	25.58	24.36
Other Operating Activities	-6.08	-11.81	-15.91	3.94	13.6	20.21
Change in Accounts Receivable	-19.24	-14.88	6.96	-24.19	-24.42	-34.97
Change in Inventory	23.28	47.36	-64.7	-60.06	30.75	24.31
Change in Accounts Payable	54.64	-16.57	-19.21	44.58	39.82	7.64
Change in Income Taxes	-5.24	-4.53	0.23	-0.98	1.69	2.87
Change in Other Net Operating Assets	-29.62	-35.03	-25.23	-34.05	-22.33	-15.02
Operating Cash Flow	344.93	293.22	181.73	181.75	273.06	172.26
Operating Cash Flow Growth	19.34%	61.35%	-0.01%	-33.44%	58.51%	58.32%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Capital Expenditures	-46.69	-32.78	-39.28	-38.13	-191.33	-96.51
Sale of Property, Plant & Equipment	1.77	1.38	23.25	1.81	1.61	2.02
Cash Acquisitions	-60.18	-60.18	-150.91	-243.85	-2.85	-2.5
Divestitures	-	-	43.29	1.5	0.85	10.64
Investment in Securities	-19.11	-36.07	-17.14	-15.55	-33.21	-
Other Investing Activities	-38.4	-51.89	-21.11	-28.17	81.14	-
Investing Cash Flow	-162.6	-179.55	-161.9	-322.39	-143.79	-86.35

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Long-Term Debt Issued	-	300	950	110	330	-
Total Debt Issued	300	300	950	110	330	-
Long-Term Debt Repaid	-	-306.25	-502.69	-72.25	-339.63	-17.5
Total Debt Repaid	-406.25	-306.25	-502.69	-72.25	-339.63	-17.5
Net Debt Issued (Repaid)	-106.25	-6.25	447.31	37.75	-9.63	-17.5
Issuance of Common Stock	9.39	7.89	8.33	7.21	7.02	6.55
Repurchase of Common Stock	-104.09	-180	-235.24	-5.89	-75	-
Other Financing Activities	-17.65	-0.1	-111.58	-0.92	-22.76	-4.8
Financing Cash Flow	-218.61	-178.46	108.82	38.16	-100.36	-15.75

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Foreign Exchange Rate Adjustments	0.56	3.46	-0.69	-3.19	-3.94	-2.98
Net Cash Flow	-35.71	-61.32	127.96	-105.67	24.97	67.19

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Free Cash Flow	298.24	260.44	142.45	143.63	81.73	75.75
Free Cash Flow Growth	16.46%	82.83%	-0.82%	75.73%	7.89%	5.56%
Free Cash Flow Margin	21.57%	19.52%	10.47%	10.97%	6.99%	7.63%
Free Cash Flow Per Share	6.43	5.50	2.81	2.79	1.59	1.48
Levered Free Cash Flow	297.44	298.09	183.89	148.53	50.09	88.9
Unlevered Free Cash Flow	319.31	310.16	206.33	160.72	58.21	89.12

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 26, 2026	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022
Cash Interest Paid	17.47	17.47	16.53	20.9	13.59	6.19
Cash Income Tax Paid	60.67	60.67	49.29	52.71	17.97	24.3
Change in Working Capital	23.82	-23.65	-101.96	-74.7	25.5	-15.18

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error